已收盘 12-07 16:00:00 美东时间
0.000
0.00%
<p>Clearmind Medicine Inc. has completed enrollment for the first cohort of its Phase I/IIa clinical trial for CMND-100, an oral drug candidate for treating Alcohol Use Disorder (AUD). Six patients were enrolled across sites at Johns Hopkins University School of Medicine and Yale School of Medicine. The trial assesses safety, tolerability, and pharmacokinetics, while exploring preliminary efficacy in reducing alcohol cravings and consumption. CEO...
10-21 11:25
Clearmind Medicine Inc. announced a historic milestone as the first participant was dosed with its proprietary CMND-100, an oral psychedelic-derived drug candidate, in a Phase I/IIa clinical trial for Alcohol Use Disorder (AUD). Conducted at leading institutions including Yale and Johns Hopkins, the trial aims to evaluate the safety, tolerability, and efficacy of CMND-100 in reducing alcohol cravings and consumption. This marks the first time the...
06-30 13:16
Clarim Acquisition Corp. (NASDAQ:CLRM – Get Rating) was the target of a signifi...
2022-09-01 01:22
油气服务巨头贝克休斯的董事长兼CEO洛伦佐·西蒙内利(Lorenzo Simonelli )周一表示,他预计到2030年,全球液化天然气(LNG)产能需要增加到...
2021-09-27 13:01
美国私人监狱运营商Geo Group的股价周三一度暴涨73%,至11美元,收盘上涨38.36%。报8.80美元。尽管该公司正在一个对私人监狱运营商日益不利的世界...
2021-06-10 11:26
根据区块链分析公司Chainalysis的一份报告,美国人2020年投资比特币的实现收益据估计达41亿美元,在全球排名第一。 Chainalysis研究总监K...
2021-06-10 10:47